Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
CASSAVA SCIENCES INC (PTIE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Schoen Eric (CFO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 150,000 options to buy
@ $17.54, valued at
$2.6M
|
|
| 10/04/2023 |
4
| Cook Robert Christopher (SVP & General Counsel) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 50,000 options to buy
@ $17.54, valued at
$877k
|
|
| 10/04/2023 |
4
| Kupiec James William (Chief Medical Officer) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 150,000 options to buy
@ $17.54, valued at
$2.6M
|
|
| 10/04/2023 |
4
| BARBIER REMI (President & CEO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 300,000 options to buy
@ $17.54, valued at
$5.3M
Granted 150,000 options to buy
@ $17.54, valued at
$2.6M
|
|
| 08/24/2023 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 30,000 shares
@ $17.45, valued at
$523.5k
|
|
| 08/23/2023 |
4
| Barry Richard (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 1,906 shares
@ $16.8, valued at
$32k
Bought 16,571 shares
@ $16.65, valued at
$275.9k
|
|
| 06/12/2023 |
4
| SCANNON PATRICK J MD PHD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 1,000 options to buy
@ $0.95, valued at
$950 |
|
| 05/25/2023 |
4
| BARBIER REMI (President and CEO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 9,545 shares
@ $25.25, valued at
$241k
Paid exercise price by delivering 47,723 shares
@ $25.25, valued at
$1.2M
Exercised 14,285 options to buy
@ $16.87, valued at
$241k
Exercised 71,428 options to buy
@ $16.87, valued at
$1.2M
|
|
| 05/10/2023 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 3,571 options to buy
@ $19.6, valued at
$70k
Exercised 3,571 options to buy
@ $16.66, valued at
$59.5k
Exercised 2,142 options to buy
@ $16.66, valued at
$35.7k
|
|
| 05/08/2023 |
4
| SCANNON PATRICK J MD PHD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 20,000 options to buy
@ $22.34, valued at
$446.8k
|
|
| 05/08/2023 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 20,000 options to buy
@ $22.34, valued at
$446.8k
Granted 5,000 options to buy
@ $22.34, valued at
$111.7k
|
|
| 05/08/2023 |
4
| O DONNELL MICHAEL J (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 20,000 options to buy
@ $22.34, valued at
$446.8k
|
|
| 05/08/2023 |
4
| GUSSIN ROBERT Z (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 20,000 options to buy
@ $22.34, valued at
$446.8k
Granted 5,000 options to buy
@ $22.34, valued at
$111.7k
|
|
| 05/08/2023 |
4
| Barry Richard (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Granted 20,000 options to buy
@ $22.34, valued at
$446.8k
Granted 5,000 options to buy
@ $22.34, valued at
$111.7k
|
|
| 03/08/2023 |
4
| O DONNELL MICHAEL J (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 2,361 shares
@ $25.2, valued at
$59.5k
Paid exercise price by delivering 2,778 shares
@ $25.2, valued at
$70k
Exercised 3,571 options to buy
@ $19.6, valued at
$70k
Exercised 3,571 options to buy
@ $16.66, valued at
$59.5k
|
|
| 03/08/2023 |
4
| Barry Richard (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 11,565 shares
@ $26.13, valued at
$302.2k
Bought 77,276 shares
@ $25.76, valued at
$2M
|
|
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2022 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 2,802 options to buy
@ $23.59, valued at
$66.1k
|
|
| 08/25/2022 |
4
| Barry Richard (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 36,159 shares
@ $23.79, valued at
$860.2k
|
|
| 08/24/2022 |
4
| Kupiec James William (Chief Clinical Dev. Officer) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 2,500 shares
@ $24.44, valued at
$61.1k
|
|
| 08/16/2022 |
4
| Schoen Eric (CFO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 2,500 shares
@ $19.95, valued at
$49.9k
|
|
| 08/16/2022 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Bought 100,000 shares
@ $20.69, valued at
$2.1M
|
|
| 06/07/2022 |
4
| BARBIER REMI (President and CEO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 54,720 shares
@ $27.93, valued at
$1.5M
Exercised 65,368 options to buy
@ $23.38, valued at
$1.5M
|
|
| 05/31/2022 |
4
| FRIEDMANN NADAV (Chief Medical Officer) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 3,071 shares
@ $26.66, valued at
$81.9k
Paid exercise price by delivering 21,498 shares
@ $26.66, valued at
$573.1k
Exercised 3,501 options to buy
@ $23.38, valued at
$81.9k
Exercised 24,513 options to buy
@ $23.38, valued at
$573.1k
|
|
| 04/25/2022 |
4
| BARBIER REMI (President and CEO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 44,791 options to buy
@ $0.95, valued at
$42.6k
Exercised 4,669 options to buy
@ $16.31, valued at
$76.2k
|
|
| 03/29/2022 |
4
| GUSSIN ROBERT Z (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 4,024 shares
@ $39.98, valued at
$160.9k
Exercised 4,669 options to buy
@ $20.3, valued at
$94.8k
Exercised 2,801 options to buy
@ $23.59, valued at
$66.1k
|
|
| 03/28/2022 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 4,670 options to buy
@ $20.3, valued at
$94.8k
|
|
| 09/21/2021 |
4
| GUSSIN ROBERT Z (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 1,746 shares
@ $43.92, valued at
$76.7k
Exercised 2,801 options to buy
@ $27.37, valued at
$76.7k
|
|
| 07/20/2021 |
4
| BARBIER REMI (President and CEO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 2,801 options to buy
@ $20.23, valued at
$56.7k
|
|
| 05/28/2021 |
4
| BARBIER REMI (President and CEO) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 53,965 shares
@ $55.6, valued at
$3M
Exercised 56,030 options to buy
@ $53.55, valued at
$3M
|
|
| 03/31/2021 |
4
| ROBERTSON SANFORD (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Exercised 2,802 options to buy
@ $27.37, valued at
$76.7k
Exercised 4,670 options to buy
@ $49, valued at
$228.8k
|
|
| 03/18/2021 |
4
| FRIEDMANN NADAV (Chief Medical Officer) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 23,996 shares
@ $62.52, valued at
$1.5M
Exercised 28,015 options to buy
@ $53.55, valued at
$1.5M
|
|
| 03/18/2021 |
4
| O DONNELL MICHAEL J (Director) has filed a Form 4 on CASSAVA SCIENCES INC|
Txns:
| Paid exercise price by delivering 4,387 shares
@ $52.16, valued at
$228.8k
Exercised 4,669 options to buy
@ $49, valued at
$228.8k
|
|
|
|
|